Pharmaceuticals

Global Biosimilar Hormones Market Overview And Prospects

November 26, 2021 by The Business Research Company

Learn about the global biosimilar hormones market through The Business Research Company, which provides information on biosimilar hormones market size, biosimilar hormones market drivers and restraints, biosimilar hormones market players, the COVID-19 impact on the biosimilar hormones market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global biosimilar hormones market is expected to grow from $1.94 billion in 2020 to $2.19 billion in 2021 at a compound annual growth rate (CAGR) of 12.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The biosimilar hormones market is expected to reach $5.35 billion in 2025 at a CAGR of 25%.

The prevalence of deficiencies in growth hormones and metabolic hormones are expected to drive innovation in biosimilar hormones, thus driving the market during the forecast period.

Request A Sample For The Global Biosimilar Hormones Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3432&type=smph

The biosimilar hormones market consists of sales of biosimilar hormones by entities that engage in manufacturing biosimilar hormones. These hormones are used when patients have a drop in hormones in their bodies or are unbalanced. Only goods and services traded between entities or sold to end consumers are included.

Global biosimilar hormones market segments include:

By Type: Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Others

By Application: Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Others

By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Speciality Clinics

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Key players operating in the biosimilar hormones market are undertaking various strategic initiatives such as new product launch in untapped regions to make the drug accessible to a large population. The companies are focusing on launching their products across various locations to boost sales and maximize profits.

TBRC’s biosimilar hormones market report covers:

Major Market Players: Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals, and GC Pharma.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Biosimilar Hormones Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides biosimilar hormones market overviews, analyzes and forecasts market size, share, biosimilar hormones market players, biosimilar hormones market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s biosimilar hormone market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Filgrastim Biosimilars Market

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model